# Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α

> **NCT01978158** · PHASE1,PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Hypoxia
- Normoxia
- Hyperoxia

## Interventions

- **DRUG:** Lipopolysaccharide

## Key facts

- **NCT ID:** NCT01978158
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978158, "Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01978158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
